Changes in gene expression and methylation in the blood of patients with first-episode psychosis

Schizophrenia Research

Volumn 159, Issue 2-3, 2014, Pages 358-364

  Ota, Vanessa Kiyomi ^a,b   Noto, Cristiano ^a,b,c   Gadelha, Ary ^a,b   Santoro, Marcos Leite ^a,b   Spindola, Leticia Maria ^a,b   Gouvea, Eduardo Sauerbronn ^a,c   Stilhano, Roberta Sessa ^a   Ortiz, Bruno Bertolucci ^a   Silva, Patricia Natalia ^a,b   Sato, João Ricardo ^b,d   Han, Sang Won ^a   Cordeiro, Quirino ^a,c   Bressan, Rodrigo Affonseca ^a,b   Belangero, Sintia Iole ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b LiNC Interdisciplinary Laboratory of Clinical Neurosciences of UNIFESP   (Brazil)

^c IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

^d UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

BH4; Biopterin; Gene expression; GTP cyclohydrolase I; Schizophrenia

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; MESSENGER RNA; RISPERIDONE;

ABAT GENE; ACTB GENE; ADULT; ARTICLE; B2M GENE; BLOOD; BLOOD SAMPLING; BRAZIL; CALGARY DEPRESSION SCALE; CHRNA7 GENE; CHRNB1 GENE; CHRNE GENE; CLINICAL GLOBAL IMPRESSION SCALE; COMT GENE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE COURSE; DNA METHYLATION; FEMALE; GABRR2 GENE; GAPDH GENE; GCH1 GENE; GCHFR GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GLOBAL ASSESSMENT OF FUNCTIONING; HOUSEKEEPING GENE; HPRT1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; NRG1 GENE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; RPL13A GENE; SCHIZOPHRENIA; TACR2 GENE; TSPO GENE;

EID: 84922518998     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.09.008     Document Type: Article

References (68)

1. Baylin S.B. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. 2005, 2(Suppl. 1):S4-S11.
2. Birchwood M., Todd P., Jackson C. Early intervention in psychosis. The critical period hypothesis. Br. J. Psychiatr. 1998, 172(33):53-59.
3. Bitanihirwe B.K., Woo T.U. Oxidative stress in schizophrenia: an integrated approach. Neurosci. Biobehav. Rev. 2011, 35(3):878-893.
4. Bjerkenstedt L., Edman G., Hagenfeldt L., Sedvall G., Wiesel F.A. Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br. J. Psychiatry 1985, 147:276-282.
5. Bodzioch M., Lapicka-Bodzioch K., Rudzinska M., Pietrzyk J.J., Bik-Multanowski M., Szczudlik A. Severe dystonic encephalopathy without hyperphenylalaninemia associated with an 18-bp deletion within the proximal GCH1 promoter. Mov. Disord. 2011, 26(2):337-340.
6. Bowden N.A., Weidenhofer J., Scott R.J., Schall U., Todd J., Michie P.T., Tooney P.A. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr. Res. 2006, 82(2-3):175-183.
7. Bressan R.A., Pilowsky L.S. Imaging the glutamatergic system in vivo-relevance to schizophrenia. Eur. J. Nucl. Med. 2000, 27(11):1723-1731.
8. Buttarelli F.R., Fanciulli A., Pellicano C., Pontieri F.E. The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders. Curr. Neuropharmacol. 2011, 9(2):278-288.
9. Carter C.J. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem. Int. 2007, 50(3):461-490.
10. de Jong S., Boks M.P., Fuller T.F., Strengman E., Janson E., de Kovel C.G., Ori A.P., Vi N., Mulder F., Blom J.D., Glenthoj B., Schubart C.D., Cahn W., Kahn R.S., Horvath S., Ophoff R.A. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One 2012, 7(6):e39498.
11. Du J., Teng R.J., Lawrence M., Guan T., Xu H., Ge Y., Shi Y. The protein partners of GTP cyclohydrolase I in rat organs. PLoS One 2012, 7(3):e33991.
12. Eells J.B., Misler J.A., Nikodem V.M. Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice. Brain Res. Bull. 2006, 70(2):186-195.
13. Eggers A.E. A serotonin hypothesis of schizophrenia. Med. Hypotheses 2013, 80(6):791-794.
14. Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 1989, 172(4-5):413-416.
15. Gattaz W.F., Waldmeier P., Beckmann H. CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr. Scand. 1982, 66(5):350-360.
16. Gil M., McKinney C., Lee M.K., Eells J.B., Phyillaier M.A., Nikodem V.M. Regulation of GTP cyclohydrolase I expression by orphan receptor Nurr1 in cell culture and in vivo. J. Neurochem. 2007, 101(1):142-150.
17. Gladkevich A., Kauffman H.F., Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2004, 28(3):559-576.
18. Gutierrez-Fernandez A., Gonzalez-Pinto A., Vega P., Barbeito S., Matute C. Expression of oligodendrocyte and myelin genes is not altered in peripheral blood cells of patients with first-episode schizophrenia and bipolar disorder. Bipolar Disord. 2010, 12(1):107-109.
19. Ichinose H., Ohye T., Takahashi E., Seki N., Hori T., Segawa M., Nomura Y., Endo K., Tanaka H., Tsuji S., et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 1994, 8(3):236-242.
20. Kabuyama Y., Suzuki T., Nakazawa N., Yamaki J., Homma M.K., Homma Y. Dysregulation of very long chain acyl-CoA dehydrogenase coupled with lipid peroxidation. Am. J. Physiol. Cell Physiol. 2010, 298(1):C107-C113.
21. Kapur S., Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am. J. Psychiatry 2001, 158(3):360-369.
22. Kaufman S. Tetrahydrobiopterin. Basic Biochemistry and Role in Human Disease 1997, Johns Hopkins University Press, Baltimore.
23. Kealey C., Roche S., Claffey E., McKeon P. Linkage and candidate gene analysis of 14q22-24 in bipolar disorder: support for GCHI as a novel susceptibility gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 136B(1):75-80.
24. Kinoshita M., Numata S., Tajima A., Shimodera S., Ono S., Imamura A., Iga J., Watanabe S., Kikuchi K., Kubo H., Nakataki M., Sumitani S., Imoto I., Okazaki Y., Ohmori T. DNA methylation signatures of peripheral leukocytes in schizophrenia. Neruomol. Med. 2013, 15(1):95-101.
25. Kordi-Tamandani D.M., Sahranavard R., Torkamanzehi A. DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia. Mol. Biol. Rep. 2012, 39(12):10889-10893.
26. Kordi-Tamandani D.M., Dahmardeh N., Torkamanzehi A. Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia. Gene 2013, 515(1):163-166.
27. Kordi-Tamandani D.M., Sahranavard R., Torkamanzehi A. Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia. Psychiatr. Genet. 2013, 23(5):183-187.
28. Kumarasinghe N., Beveridge N.J., Gardiner E., Scott R.J., Yasawardene S., Perera A., Mendis J., Suriyakumara K., Schall U., Tooney P.A. Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication. Int. J. Neuropsychopharmacol. Off. Sci. J. Coll. Int. Neuropsychopharmacol 2013, 16(7):1483-1503.
29. Kurian S.M., Le-Niculescu H., Patel S.D., Bertram D., Davis J., Dike C., Yehyawi N., Lysaker P., Dustin J., Caligiuri M., Lohr J., Lahiri D.K., Nurnberger J.I., Faraone S.V., Geyer M.A., Tsuang M.T., Schork N.J., Salomon D.R., Niculescu A.B. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol. Psychiatry 2011, 16(1):37-58.
30. Kuzman M.R., Medved V., Terzic J., Krainc D. Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia. J. Psychiatr. Res. 2009, 43(13):1073-1077.
31. Lee J., Goh L.K., Chen G., Verma S., Tan C.H., Lee T.S. Analysis of blood-based gene expression signature in first-episode psychosis. Psychiatry Res. 2012, 200(1):52-54.
32. Leucht S., Davis J.M., Engel R.R., Kissling W., Kane J.M. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation. Acta Psychiatr. Scand. 2009, 438:7-14.
33. Lima M.S., Soares B.G., Paoliello G., Machado Vieira R., Martins C.M., Mota Neto J.I., Ferrao Y., Schirmer D.A., Volpe F.M. The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study. Rev. Bras. Psiquiatr. 2007, 29(3):246-249.
34. Lindstrom L.H. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history. Psychiatry Res. 1985, 14(4):265-273.
35. Liu J., Chen J., Ehrlich S., Walton E., White T., Perrone-Bizzozero N., Bustillo J., Turner J.A., Calhoun V.D. Methylation patterns in whole blood correlate with symptoms in schizophrenia patients. Schizophr. Bull. 2014, 40(4):769-776.
36. Liu L., Yuan G., Cheng Z., Zhang G., Liu X., Zhang H. Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients. PLoS One 2013, 8(9):e75259.
37. Maschietto M., Silva A.R., Puga R.D., Lima L., Pereira C.B., Nakano E.Y., Mello B., Gama C.S., Belmonte-de-Abreu P., Carraro D.M., Palha J.A., Brentani H. Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls. Psychiatry Res. 2012, 200(2-3):1018-1021.
38. Melas P.A., Rogdaki M., Osby U., Schalling M., Lavebratt C., Ekstrom T.J. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. Faseb J. 2012, 26(6):2712-2718.
39. Middleton F.A., Pato C.N., Gentile K.L., McGann L., Brown A.M., Trauzzi M., Diab H., Morley C.P., Medeiros H., Macedo A., Azevedo M.H., Pato M.T. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 136B(1):12-25.
40. Nishioka M., Bundo M., Koike S., Takizawa R., Kakiuchi C., Araki T., Kasai K., Iwamoto K. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J. Hum. Genet. 2013, 58(2):91-97.
41. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Hashimoto R., Takeda M., Kunugi H., Itakura M., Ohmori T. TGFBR2 gene expression and genetic association with schizophrenia. J. Psychiatr. Res. 2008, 42(6):425-432.
42. Onwumere J., Bebbington P., Kuipers E. Family interventions in early psychosis: specificity and effectiveness. Epidemiol. Psychiatr. Sci. 2011, 20(2):113-119.
43. Ota V.K., Noto C., Gadelha A., Santoro M.L., Silva P.N., Melaragno M.I., Smith Mde A., Cordeiro Q., Bressan R.A., Belangero S.I. Neurotransmitter receptor and regulatory gene expression in peripheral blood of Brazilian drug-naive first-episode psychosis patients before and after antipsychotic treatment. Psychiatry Res. 2013, 210(3):1290-1292.
44. Potkin S.G., Weinberger D.R., Linnoila M., Wyatt R.J. Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles. Am. J. Psychiatry 1983, 140(1):21-25.
45. Reinius L.E., Acevedo N., Joerink M., Pershagen G., Dahlen S.E., Greco D., Soderhall C., Scheynius A., Kere J. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012, 7(7):e41361.
46. Richardson M.A., Read L.L., Taylor Clelland C.L., Reilly M.A., Chao H.M., Guynn R.W., Suckow R.F., Clelland J.D. Evidence for a tetrahydrobiopterin deficit in schizophrenia. Neuropsychobiology 2005, 52(4):190-201.
47. Richardson M.A., Read L.L., Reilly M.A., Clelland J.D., Clelland C.L. Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder. Neurochem. Res. 2007, 32(1):107-113.
48. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
49. Segawa M., Nomura Y., Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann. Neurol. 2003, 54(Suppl. 6):S32-S45.
50. Sequeira P.A., Martin M.V., Vawter M.P. The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol. Dis. 2012, 45(1):23-36.
51. Serova L., Sabban E.L. Involvement of alpha 7 nicotinic acetylcholine receptors in gene expression of dopamine biosynthetic enzymes in rat brain. J. Pharmacol. Exp. Ther. 2002, 303(3):896-903.
52. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
53. Snyder S.H., Ferris C.D. Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry 2000, 157(11):1738-1751.
54. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Moller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Muhleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nothen M.M., Peltonen L., Collier D.A., St Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455(7210):232-236.
55. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460(7256):744-747.
56. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60(12):1187-1192.
57. Suzuki K., Nakamura K., Iwata Y., Sekine Y., Kawai M., Sugihara G., Tsuchiya K.J., Suda S., Matsuzaki H., Takei N., Hashimoto K., Mori N. Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients. Schizophr. Res. 2008, 98(1-3):148-156.
58. Takahashi M., Hayashi H., Watanabe Y., Sawamura K., Fukui N., Watanabe J., Kitajima T., Yamanouchi Y., Iwata N., Mizukami K., Hori T., Shimoda K., Ujike H., Ozaki N., Iijima K., Takemura K., Aoshima H., Someya T. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr. Res. 2010, 119(1-3):210-218.
59. Trender-Gerhard I., Sweeney M.G., Schwingenschuh P., Mir P., Edwards M.J., Gerhard A., Polke J.M., Hanna M.G., Davis M.B., Wood N.W., Bhatia K.P. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J. Neurol. Neurosurg. Psychiatry 2009, 80(8):839-845.
60. Tsai M.J., Lee E.H. Nicotine enhances brain biopterin concentration in rats. Neurochem. Int. 1995, 27(2):213-217.
61. Tsai M.J., Wang H.L., Lee E.H. Interactive effects of nicotine and MPTP on striatal tetrahydrobiopterin in mice. J. Biomed. Sci. 1996, 3(1):47-53.
62. Tsuang M.T., Nossova N., Yager T., Tsuang M.M., Guo S.C., Shyu K.G., Glatt S.J., Liew C.C. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 133B(1):1-5.
63. Van Hove J.L., Steyaert J., Matthijs G., Legius E., Theys P., Wevers R., Romstad A., Moller L.B., Hedrich K., Goriounov D., Blau N., Klein C., Casaer P. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J. Neurol. Neurosurg. Psychiatry 2006, 77(1):18-23.
64. Vessoni A.L. Adaptação e estudo de confiabilidade da escala de avaliação das síndromes positiva e negativa para a esquizofrenia no Brasil 1993, Escola Paulista de Medicina, São Paulo.
65. Wang G., Hu C., Jiang T., Luo J., Hu J., Ling S., Liu M., Xing G. Overexpression of serotonin receptor and transporter mRNA in blood leukocytes of antipsychotic-free and antipsychotic-naive schizophrenic patients: gender differences. Schizophr. Res. 2010, 121(1-3):160-171.
66. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., Brown P.O. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(4):1896-1901.
67. Xing G., Zhang L., Russell S., Post R. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr. Res. 2006, 84(1):36-56.
68. Zhang H.X., Zhao J.P., Lv L.X., Li W.Q., Xu L., Ouyang X., Yuan Z.Q., Huang J.S. Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia. Neurosci. Lett. 2008, 438(1):1-5.